CLAIRE ERNST

Hill outreach on stopping the Medicare cuts and our advocacy agenda for 2024: protecting the financial viability of medical group practices, reducing prior authorization burden, advancing value-based care, improving quality reporting, maintaining access to care through telehealth, expanding the physician workforce, improving implementation of No Surprises Act requirements, and supporting the effective and ethical application of artificial intelligence technology. Telehealth: Submitted testimony to the House Committee on Ways and Means hearing, Enhancing Access to Care at Home in Rural and Underserved Communities. Laboratory developed tests: Submitted testimony to House Energy and Commerce Subcommittee on Health hearing on laboratory developed tests, Evaluating Approaches to Diagnostic Test Regulation and the Impact of FDAs Proposed Rule. Artificial intelligence: Submitted testimony to Senate Finance Committee hearing, Artificial Intelligence and Health Care: Promise and Pitfalls. Graduate medical education: Letter supporting the Substance Use Disorder Workforce Act (H.R. 7050). Information blocking: Submitted comments to CMS and ONC on the information blocking disincentives for providers proposed rule. Cybersecurity: Letter to HHS in response to the Change Healthcare cyberattack impact on medical groups. Medicare cuts rebilling clarification: Letter to CMS asking for rebilling clarification if Medicare cuts were retroactively addressed.

MEDICAL GROUP MANAGEMENT ASSN